Data as of:
brimindinvest.com / compare / smr-vs-nneLIVE
SMR
NuScale Power Corporation · Utilities / Nuclear Technology
$8.42
-9.17% this month
VERSUS
COMPARE
NNE
NANO Nuclear Energy Inc. · Utilities / Nuclear Technology
$16.99
-8.16% this month
Comparison scoreboard
NNE LEADS 4/5
AI Scorei
SMR 21.5
NNE ✓31.5
1Y Returni
SMR -77.67%
NNE ✓-58.96%
Fwd P/Ei
SMR ✓-14.67
NNE -17.83
Target Up.i
SMR +32.15%
NNE ✓+132.14%
Op. Margini
SMR -85337.33%
NNE ✓-7378.27%
Metrics last refreshed: 9/27/2026
Quick take

SMR vs NNE Stock Comparison: AI Score, Valuation, Performance and Upside

ShareXLinkedInRedditFacebookWhatsApp

SMR and NNE are both pre-revenue nuclear developers, which makes this a comparison of maturity rather than of profits. NuScale has an NRC-approved light-water SMR design and a commercial licensing partner. NANO Nuclear is considerably earlier, pursuing microreactor concepts that have not yet entered formal design certification. Neither is valued on current earnings, so the practical question is how much regulatory progress an investor is getting for the risk taken.

Use this SMR vs NNE comparison to grade each company on verifiable milestones rather than narrative. In pre-revenue nuclear, the things that actually de-risk a business are regulatory approvals, signed customer commitments, and funded construction decisions. Press releases and memoranda of understanding are not the same thing.

Live analysis · updated 9/27/2026

NNE holds the edge across 4 of 5 key metrics in this comparison. NNE has delivered stronger 1-year price return (-58.96% vs -77.67%), though SMR has the better forward P/E setup (-14.67x vs -17.83x for NNE). Analyst consensus implies meaningfully more upside for NNE (+132.14%) than for SMR (+32.15%).

Want a full valuation workup? 46-section report — AI Score, Monte Carlo forecast, bull/bear case, DCF, and more.
Normalized 1Y performance
SMR
NNE
Recent returns
SMR
NNE
Analyst price targets & sentiment

Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.

SMR
Price target range
analyst mean$12.63
current price$8.42
+32.1% upside to analyst mean
NNE
Price target range
analyst mean$40.83
current price$16.99
+132.1% upside to analyst mean
Who should consider this stock?
SMR may suit investors who:
  • Want the most regulatory-advanced pure-play small modular reactor design in the US
  • Prefer proven light-water technology over novel reactor physics
  • Accept dilution risk but want it attached to a company with a certified design
  • Are looking for speculative nuclear exposure with somewhat more institutional scrutiny
NNE may suit investors who:
  • Are willing to take very early-stage risk for correspondingly higher potential upside
  • Believe microreactors for remote and industrial sites will be licensed sooner than expected
  • Understand the position could be diluted repeatedly before any revenue appears
  • Are sizing it as a speculative holding rather than a core energy position
Performance & AI score
Performance & AI score
MetricSMRNNE
AI scorei21.531.5
AI ranki#4699#2104
Latest closei$8.42$16.99
1M returni-9.17%-8.16%
6M returni-18.25%-16.26%
1Y returni-77.67%-58.96%
$10,000 invested — hypothetical growth (dividends reinvested)

How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?

$10,000 invested — hypothetical growth (dividends reinvested)
PeriodSMRNNE
1Y ago$2.23K (-77.7%)
started 2025-09-25
$4.1K (-59.0%)
started 2025-09-25
5Y ago$8.37K (-16.3%)
started 2022-03-01
$32.74K (+227.4%)
started 2024-05-08
10Y ago$8.37K (-16.3%)
started 2022-03-01
$32.74K (+227.4%)
started 2024-05-08

Hypothetical — past performance does not guarantee future results.

Valuation & upside potential
Valuation & upside potential
MetricSMRNNE
Market capi$3.92B$944.55M
Trailing P/EiN/AN/A
Forward P/Ei-14.67-17.83
Price/SalesiN/AN/A
EV/Revenuei249.451678.67
Analyst targeti$12.63$40.83
Target upsidei+32.15%+132.14%
Growth, profitability & risk
Growth, profitability & risk
MetricSMRNNE
Revenue growthi-99.10%N/A
Earnings growthiN/AN/A
EPS growthiN/AN/A
FCF margini-1913.88%-16565.93%
Operating margini-85337.33%-7378.27%
Profit margini0.00%0.00%
ROIC proxyi-55.18%-8.04%
Return on equityi-55.18%-8.04%
Dividend yieldiN/AN/A
Payout ratioi0.00%0.00%
Dividend growth streakiN/AN/A
Betai2.315.41
Debt/equityi0.330.46
Current ratioi37.8879.18
Quick ratioi37.3478.72
Correlation

Over the past year, SMR and NNE have moved strongly in the same direction (correlation of 0.78), based on daily returns.

1Y
0.78
-1.0+1.0
5Y
0.54
-1.0+1.0
10Y
0.54
-1.0+1.0
Drawdown & downside risk

Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.

1Y risk snapshot
SMR max drawdowni85.79%
NNE max drawdowni73.72%
SMR max wkly dropi35.02%
NNE max wkly dropi29.56%
5Y risk snapshot
SMR max drawdowni87.47%
NNE max drawdowni77.68%
SMR max wkly dropi59.70%
NNE max wkly dropi42.77%
10Y risk snapshot
SMR max drawdowni87.47%
NNE max drawdowni77.68%
SMR max wkly dropi59.70%
NNE max wkly dropi42.77%
Performance metrics by period
Performance metrics by period
PeriodMetricSMRNNE
1YGrowthi-77.67%-58.96%
CAGRi-77.69%-58.99%
Volatilityi100.13%96.55%
Sharpe ratioi-1.05-0.50
Sortino ratioi-1.48-0.75
Max drawdowni85.79%73.72%
Current drawdowni84.24%70.00%
Avg drawdowni67.82%51.02%
Ulcer Indexi71.33%53.88%
Max daily dropi15.67%16.93%
Max wkly dropi35.02%29.56%
5YGrowthi-16.30%+227.36%
CAGRi-3.82%+64.52%
Volatilityi99.75%142.20%
Sharpe ratioi0.411.00
Sortino ratioi0.641.74
Max drawdowni87.47%77.68%
Current drawdowni84.24%70.00%
Avg drawdowni43.33%39.89%
Ulcer Indexi51.05%44.59%
Max daily dropi34.85%32.47%
Max wkly dropi59.70%42.77%
10YGrowthi-16.30%+227.36%
CAGRi-3.82%+64.52%
Volatilityi99.75%142.20%
Sharpe ratioi0.411.00
Sortino ratioi0.641.74
Max drawdowni87.47%77.68%
Current drawdowni84.24%70.00%
Avg drawdowni43.33%39.89%
Ulcer Indexi51.05%44.59%
Max daily dropi34.85%32.47%
Max wkly dropi59.70%42.77%
AI Prediction Signali
Members only
Next 5 trading days
SMR
+2.8%BUY
NNE
+1.1%HOLD
Next 30 trading days
SMR
+6.4%BUY
NNE
+3.2%HOLD

Sign up to unlock AI price predictions

ML model trained on historical prices · 14-day free trial · No credit card required
Business comparison
Business comparison
CategorySMRNNE
CompanyNuScale Power CorporationNANO Nuclear Energy Inc.
SectorIndustrialsIndustrials
IndustrySpecialty Industrial MachinerySpecialty Industrial Machinery
Core businessDesigner of light-water small modular reactors, licensed commercially through partner ENTRA1. NuScale's module holds US Nuclear Regulatory Commission design approval, the first granted to an SMR.Early-stage developer of portable and micro nuclear reactor concepts aimed at remote sites, industrial users, and defense applications, alongside interests in nuclear fuel transport and consulting services.
Investor focusCustomer orders, progress toward a final investment decision on a first plant, regulatory approval of the uprated module, and cash runway.Whether any reactor concept advances into formal NRC licensing, cash position versus burn, dilution from share issuance, and credibility of the technical roadmap.
SMR strengths
  • First and furthest along the NRC approval path of any US small modular reactor design
  • Light-water technology relies on a well-understood fuel and regulatory precedent rather than novel physics
  • Larger scale and institutional visibility than most early-stage nuclear developers
NNE strengths
  • Targets microreactor niches such as remote power and industrial heat where grid connection is impractical
  • Small size means any credible licensing milestone could move the shares sharply
  • Has built a technical and advisory bench to pursue multiple reactor concepts in parallel
Risks to watch — SMR
  • Still pre-commercial, with no plant delivering electricity to a paying customer
  • History of a cancelled flagship project after cost escalation
  • Dependent on partners and customers to fund actual plant construction
Risks to watch — NNE
  • Substantially earlier stage than NuScale, with no approved reactor design
  • Pre-revenue with recurring equity issuance, an ongoing source of dilution
  • Microreactor licensing in the US has no completed commercial precedent, so timelines are highly uncertain
Frequently asked questions
Regulatory stage and technology. NuScale designs light-water small modular reactors and has received NRC design approval, the first SMR to do so. NANO Nuclear is developing much smaller portable and micro reactor concepts that have not completed formal design certification. Both are pre-revenue, but NuScale is measurably further along the licensing path.
Interactive comparison engine

Compare more than two at a time

This page is a fixed writeup on SMR and NNE. Our comparison engine is the interactive version: load up to five tickers, switch timeframes, and get the correlation, drawdown, and overlap analysis that a static page can't show.

Up to 5 tickers at once

Add three more names beside SMR and NNE, mixing stocks and ETFs in the same table — useful when the real question is which of a whole peer group to own.

Scoreboard verdict

AI score, forward P/E, analyst target upside, operating margin, and revenue growth are scored head-to-head, with a running tally of which ticker leads on how many metrics.

Full risk suite

Volatility, Sharpe and Sortino ratios, maximum, current, and average drawdown, Ulcer Index, and worst single-day and single-week drops across every timeframe.

Correlation heatmap

Pairwise daily-return correlation for every combination, so you can see whether two holdings actually diversify each other or just move together.

Valuation vs profitability

A scatter plot of forward P/E against return on equity, plus drawdown and 30-day rolling volatility charts, to separate what is cheap from what is merely beaten down.

Holdings overlap and CSV export

For ETFs, a top-holdings comparison that exposes hidden overlap between funds. Every comparison exports to CSV for your own spreadsheet work.

Two comparisons a week are free without an account. A 14-day trial removes the limit and adds AI price forecasts, stock rankings, saved watchlists, and the intrinsic value calculator — no credit card required.

Free public comparison

Want deeper AI forecasts?

This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.

In-Depth Reports

Full valuation workup with AI Score, Monte Carlo forecast, and bull/bear case — free preview, premium data from $3.99.

Related comparisons
More comparisons
Browse all 1,000 comparisons
ShareXLinkedInRedditFacebookWhatsApp